User menu

Both Phenolic and Acyl Glucuronidation Pathways of Diflunisal Are Impaired in Liver-cirrhosis

Bibliographic reference Macdonald, JI. ; Wallace, SM. ; Mahachai, V. ; Verbeeck, RK.. Both Phenolic and Acyl Glucuronidation Pathways of Diflunisal Are Impaired in Liver-cirrhosis. In: European Journal of Clinical Pharmacology, Vol. 42, no. 5, p. 471-474 (1992)
Permanent URL
  1. Dickinson RG, King AR (1989) Reactivity considerations in the analysis of glucuronide and sulfate conjugates of diflunisal. Ther Drug Monit 11: 712?720
  2. Houston JB (1982) Drug metabolite kinetics. Pharmac Ther 15: 521?552
  3. Howden CW, Birnie GG, Brodie MJ (1988) Drug metabolism in liver disease. Pharmac Ther 40: 439?474
  4. Hoyumpa AM, Schenker S (1991) Is glucuronidation truly preserved in patients with liver disease? Hepatology 13: 786?795
  5. Loewen GR, Herman RJ, Ross SG, Verbeeck RK, Effect of dose on the glucuronidation and sulphation kinetics of diflunisal in man: single dose studies., 10.1111/j.1365-2125.1988.tb03360.x
  6. Loewen GR, Macdonald JI, Verbeeck RK (1989) High-performance liquid chromatographic method for the simultaneous quantitation of diflunisal and its glucuronide and sulfate conjugates in human urine. J Pharm Sci 78: 250?255
  7. Loewen GR, McKay G, Verbeeck RK (1986) Isolation and identification of a new major metabolite of diflunisal in man. The sulfate conjugate. Drug Metab Disp 14: 127?131
  8. Macdonald JI, Dickinson RG, Reid RS, Edom RW, King AR, Verbeeck RK (1991) Identification of a hydroxy metabolite of diflunisal in rat and human urine. Xenobiotica 21: 1521?1533
  9. Mazoit JX, Sandouk P, Scherrmann J-P, Roche A (1990) Extrahepatic metabolism of morphine occurs in humans. Clin Pharmacol Ther 48: 613?618
  10. Mazoit J-X, Sandouk P, Zelaoui P, Scherrmann J-M (1987) Pharmacokinetics of unchanged morphine in normal and cirrhotic patients. Anesth Analg 66: 293?298
  11. McLean AJ, Morgan DJ (1991) Clinical pharmacokinetics in patients with liver disease. Clin Pharmacokinet 21: 42?69
  12. Patwardhan RV, Johnson RF, Hoyumpa A, Sheehan JJ, Desmond PV, Wilkinson GR, Branch RA, Schenker S (1981) Normal metabolism of morphine in cirrhosis. Gastroenterology 81: 1006?1011
  13. Shull HJ, Wilkinson GR, Johnson R, Schenker S (1976) Normal disposition of oxazepam in acute viral hepatitis and cirrhosis. Ann Intern Med 84: 420?425
  14. Sonne J, Anderson PB, Loft S, Døssing M, Andreasen F (1990) Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy. Hepatology 11: 951?956
  15. Taburet A-M, Naveau S, Zora G, Colin J-N, Delfraissy J-F, Chaput J-C, Singlas E (1990) Pharmacokinetics of zidovudine in patients with liver disease. Clin Pharmacol Ther 47: 731?739
  16. Tocco DJ, Breault GO, Zacchei AG, Steelman SL, Perrier CV (1975) Physiological disposition and metabolism of 5-(2?,4?-difluorophenyl)salicylic acid, a new salicylate. Drug Metabol Disposit 6: 453?466
  17. Tozer TN (1986) Concepts basic to pharmacokinetics. In: Rowland M, Tucker G (eds). Pharmacokinetics: Theory and Methodology. Pergamon Press, Oxford, pp 29?51
  18. Tozer TN, Gambertoglio JG, Furst DE, Avery DS, Holford NHG (1983) Volume shifts and protein binding estimates using equilibrium dialysis: application to prednisolone binding in humans. J Pharm Sci 72: 1442?1446
  19. Verbeeck RK, Dickinson RG (1990) The role of sulfate conjugation in the elimination kinetics of diflunisal in the rat. Drug Metab Disp 18: 267?268
  20. Verbeeck RK, Loewen GR, Macdonald JI, Herman RJ (1990) The effect of multiple dosage on the kinetics of glucuronidation and sulphation of diflunisal in man. Br J Clin Pharmacol 29: 381?389
  21. Williams RL (1986) Protein binding in hepatic disease: pharmacokinetic and clinical implications. In: Tillement J-P, Lindenlaub E (eds) Protein binding and drug transport. Schattauer, Stuttgart, pp 375?391
  22. Williams RL, Upton RA, Cello JP, Jones RM, Blitstein M, Kelly J, Nierenburg D (1984) Naproxen disposition in patients with alcoholic cirrhosis. Eur J Clin Pharmacol 27: 291?296
  23. Witassek F, Bircher J, Huguenin P, Preisig R (1983) Abnormal glucuronidation of zomepirac in patients with cirrhosis of the liver. Hepatology 11: 415?422